Author

Andrew Siderowf

Observed names: A. Siderowf, Siderowf, A., Siderowf, Andrew

Institution: University of Pennsylvania

Observed institutions: Northwestern University, Cleveland Clinic, Shirley Ryan AbilityLab, Hospital of the University of Pennsylvania, Pennsylvania Hospital, Avid Radiopharmaceuticals (United States), University of Pennsylvania

ORCID: 0000-0002-1750-7698

Observed ORCID: 0000-0002-1750-7698

OpenAlex ID: A5111907334

Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology

2012 · D. Cella, J.-S. Lai, et al. · Neurology · 804

Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival

2002 · Susan Gregory, Andrew Siderowf, et al. · Neurology · 112

Breaking the news: A survey of ALS patients and their caregivers

2004 · Leo Mccluskey, David Casarett, et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · 92

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

2017 · Michael J. Pontecorvo, Anupa K. Arora, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 69

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

2019 · Neha Prakash, Chelsea Caspell-Garcia, et al. · Parkinsonism & Related Disorders · 19

Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder

2025 · Daniel Weintraub, Anuprita R. Nair, et al. · Annals of Neurology · 8

P4‐314: Test‐retest Data for the Tau Pet Imaging Agent 18f‐av‐1451 (previously, 18f‐t807)

2014 · Michael D. Devous, Abhinay D. Joshi, et al. · Alzheimer s & Dementia · 4

[o5–01–01]: Pet Biomarkers in the Expedition 3 Trial of Patients With Mild Ad

2017 · Mark A. Mintun, Michael D. Devous, et al. · Alzheimer s & Dementia · 3

Differential Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status

2026 · Houman Azizi, Seyed-Mohammad Fereshtehnejad, et al. · medRxiv

Supplementary Material for: Effectiveness of Florbetapir PET Imaging in Changing Patient Management

2017 · Pontecorvo, M.J., Siderowf, A., et al. · Figshare

O4‐07‐01: Evolution of [18F]Av‐1451 Pet Tau Signal: Interim Analysis of an 18‐Month Phase 2 Study

2016 · Mark A. Mintun, Michael D. Devous, et al. · Alzheimer s & Dementia

Supplementary Material for: Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria

2016 · Grundman, M., Johnson, K.A., et al. · Figshare

O4‐01‐02: Effect of Amyloid Imaging on Diagnosis and Management of Patients With Cognitive Decline: Impact of Appropriate Use Criteria

2014 · Andrew Siderowf, Michael Pontecorvo, et al. · Alzheimer s & Dementia

Ongoing development of analysis strategies with [F-18]-T807 (AV-1451): A PET biomarker for tau deposits

2014 · Mark A. Mintun, Abhinay D. Joshi, et al. · Journal of Nuclear Medicine

Reliability of visual interpretation of 5 min and 10 min florbetapir F18 scans from ADNI database

2013 · Anupa Arora, Michael J. Pontecorvo, et al. · Journal of Nuclear Medicine

Works count: 23

Citation count: 1,130

H-index: 7

I10-index: 6